Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Molecular Mechanism and Therapeutic Progress in Glomus Tumor.

Cancer medicine - 1 Feb 2026

Jiang Zhi Cheng, Cheng Zu Jue, Xiao Jue Xian, Huang You Quan, Ke Zheng, Xu Jing Hui, Fu Xiang Kun, Huang Hui

Abstract excerpt

BACKGROUND: Glomus tumor (GT) is a rare mesenchymal neoplasm presumed to originate from the neuromyoarterial glomus body. Its pathogenesis is complex and involves alterations in multiple genes and signaling pathways. In the era of precision medicine, increased molecular research has begun to elucidate the oncogenic drivers of GT, offering novel potential directions for targeted treatment strategies. METHODS: This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to NF1 gene
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 41693210
DOI: 10.1002/cam4.71588
PMCID: PMC12907513

Genes

NF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Molecular Mechanism and Therapeutic Progress in Glomus Tumor.PMID 41693210Read ↗

BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics.Semantic proximity Read ↗

A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation.Semantic proximity Read ↗

Primary sellar glomus tumor with BRAF K601E mutation: an aggressive tumor of uncertain malignant potential.Semantic proximity Read ↗

Combined treatment for a rare malignant glomus tumor of the esophagus with pulmonary and liver metastases: a case report and review of literatureSemantic proximity Read ↗

BRAF and KRAS mutations in sporadic glomus tumors.Semantic proximity Read ↗

Metastatic Malignant Gastric Glomus Tumour: Multidisciplinary Diagnosis & Treatment of a Rare Clinical EntitySemantic proximity Read ↗

Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel AssociationSemantic proximity Read ↗

Elimination of BRAF p.V600E under selective pressure of BRAF-targeted therapy and expansion of a PIK3CA p.E542K clone in a patient with recurrent malignant glomus tumorSemantic proximity Read ↗

A Molecular Reappraisal of Glomus Tumors and Related Pericytic Neoplasms With Emphasis on NOTCH-gene FusionsSemantic proximity Read ↗

Clinicopathologic features and BRAF mutation status of tracheal glomus tumors - Characterization of 4 cases and the distinction from low-grade neuroendocrine tumors.Semantic proximity Read ↗

Intraneural glomus tumor of "uncertain malignant potential" and with BRAF mutation in the median nerve - an unusual case.Semantic proximity Read ↗

PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.